The synthesis and structure−activity relationship studies of novel indole derivatives as
peroxisome proliferator-activated receptor (PPAR) agonists are reported. Indole, a druglike
scaffold, was studied as a core skeleton for the acidic head part of PPAR agonists. The structural
features (acidic head, substitution on indole, and linker) were optimized first, by keeping
benzisoxazole as the tail part, based on binding and functional activity at PPARγ protein. The
variations in the tail part, by introducing various heteroaromatic ring systems, were then
studied. In vitro evaluation led to identification of a novel series of indole compounds with a
benzisoxazole tail as potent PPAR agonists with the lead compound 14 (BPR1H036) displaying
an excellent pharmacokinetic profile in BALB/c mice and an efficacious glucose lowering activity
in KKAy mice. Structural biology studies of 14 showed that the indole ring contributes strong
hydrophobic interactions with PPARγ and could be an important moiety for the binding to the
protein.